HCWM
KRYS icon

Hidden Cove Wealth Management’s Krystal Biotech KRYS Stock Holding History

Hidden Cove Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Sell
1,220
-82
-6% -$24.5K 0.25% 66
2026
Q1 		$336K Buy
1,302
+443
+52% +$118K 0.22% 70
2025
Q4 		$212K Buy
+859
New +$181K 0.14% 94

Other funds holding KRYS

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
CWS
Confluence Wealth Services Mcmurray, Pennsylvania $3.5B AUM 22.08% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

Hidden Cove Wealth Management's KRYS Position: Q2 2026 in Review

Hidden Cove Wealth Management reduced its Krystal Biotech (KRYS) stake by 6.3% in Q2 2026, selling an estimated $24.5K and leaving 1,220 shares worth $453K. The position accounts for 0.25% of the portfolio, ranked #66.

Hidden Cove Wealth Management first reported a position in KRYS in Q4 2025 and has held it in 3 quarters since. 51 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Hidden Cove Wealth Management held 1,220 shares of Krystal Biotech worth $453K as of Q2 2026.
  • Hidden Cove Wealth Management sold 82 Krystal Biotech shares in Q2 2026, an estimated $24.5K.
  • Krystal Biotech made up 0.25% of Hidden Cove Wealth Management's portfolio in Q2 2026, its #66 holding.
  • Hidden Cove Wealth Management first reported a position in Krystal Biotech in Q4 2025 and has held it in 3 quarters since.
  • 51 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Hidden Cove Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.